Conclusions

Our practice of medicine will benefit by continuing to focus on as well as advance our understanding of the relationship between ED, endothelial dysfunction, and CVD. Furthermore, the urological community has a responsibility to consider the increased cardiovascular morbidity and mortality in our ED patients more seriously and together with our medical colleagues need to further refine the clinical algorithms for the screening of the ED patient for latent CVD.

 

Continue Reading

An associate clinical professor of urology at the University of Connecticut Health Center in Farmington, Conn., Dr. Honig practices at the Urology Center in New Haven, Conn. and is a member of the Renal & Urology News editorial advisory board. Dr. Bar-Chama is an associate professor in both the Department of Urology and the Department of Obstetrics, Gynecology, and Reproductive Science at The Mount Sinai School of Medicine in New York.

 

References

  1. Grover SA, Lowensteyn I, Kaou-ache M, et al. The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease. Arch Intern Med. 2006;166:213-219.         
  2. Pritzker MR. The penile stress test: a window to the hearts of man.  Circulation 1999;100:I-711 (abstract no. 3751).
  3. Montorsi P, Ravagnani PM, Galli S, et al. Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient. Eur Urol. 2006;50:721-731.       
  4. Blumentals WA, Gomez-Cam-inero A, Joo S, Vannappagari V. Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. Int J Impot Res. 2004;16:350-353.    
  5. Gazzaruso C, Giordanetti S, De Amici E, et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation. 2004;110:22-26.  
  6. Kaiser DR, Billups K, Mason C, et al. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol. 2004;43:179-184.       
  7. Jackson G, Rosen RC, Kloner RA, Kostis JB. The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med. 2006;3:28-36.
  8. Billups KL, Bank AJ, Padma-Nathan H, et al. Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel. J Sex Med. 2005;2:40-50.
  9. Mazo E, Gamidov S, Iremashvili V. The effect of vardenafil on endothelial function of brachial and cavernous arteries. Int J Impot Res. 2006;18:464-469.
  10. Ucar G, Secil M, Demir O, et al. The combined use of brachial artery flow-mediated dilatation and carotid artery intima-media thickness measurements may be a method to determine vasculogenic erectile dysfunction. Int J Impot Res. 2007;19:577-583.
  11. Khera M, Mohamed O, Schumacher M. Endothelial function scores can predict which patients will have arterial insufficiency and venous leak on penile duplex ultrasound. J Sex Med. 2008;5(Suppl 1):24.
  12. Rosano GM, Aversa A, Vitale C, et al. Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol. 2005;47:214-220.      
  13. Aversa A, Greco E, Bruzziches R, et al. Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res. 2007;19:200-207.

From the February 01, 2008 Issue of Renal and Urology News

Topics:

Erectile Dysfunction